M. Whelan

发表

CEL-1000--a peptide with adjuvant activity for Th1 immune responses.

K. Rosenthal, Y. Charoenvit, N. Goel, 2004, Vaccine.

A novel, helminth‐derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56+ cells for its action

N. A. Libri, W. Rosenberg, A. Semper, 2008, Clinical and experimental immunology.

Biomarkers for development of cancer vaccines.

G. Ball, A. Dalgleish, M. Whelan, 2006, Personalized medicine.

Heat-Shock Protein 60-Reactive CD4+CD28null T Cells in Patients With Acute Coronary Syndromes

Qingbo Xu, J. Kaski, J. Madrigal, 2004, Circulation.

Sulphydryl reactivity of the HLA-B27 epitope: accessibility of the free cysteine studied by flow cytometry.

D. Perrett, M. Macey, M. Lowdell, 1992, Annals of the rheumatic diseases.

Immunotherapeutic potential of whole tumour cells

H. Pandha, A. Dalgleish, S. Todryk, 2002, Cancer Immunology, Immunotherapy.

A novel murine model of allogeneic vaccination against prostate cancer

A. Dalgleish, S. Todryk, C. Bangma, 2008, Cancer Immunology, Immunotherapy.

A novel murine model of allogeneic vaccination against renal cancer

H. Pandha, S. Ward, E. Havranek, 2008, BJU international.

Vaccine‐induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD‐1 and chronicity

B. Bartosch, F. Cosset, J. Heeney, 2007, Hepatology.

Control of Heterologous Hepatitis C Virus Infection in Chimpanzees Is Associated with the Quality of Vaccine-Induced Peripheral T-Helper Immune Response

J. Heeney, A. Fatmi, G. Inchauspé, 2004, Journal of Virology.

An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma.

H. Pandha, E. Havranek, M. Whelan, 2005, The Journal of urology.

Heat-Shock Protein 60–Reactive CD4 CD28 T Cells in Patients With Acute Coronary Syndromes

G. Arno, C. Baboonian, M. Whelan, 2004 .

Heat-Shock Protein 60 – Reactive CD 4 CD 28 null T Cells in Patients With Acute Coronary Syndromes

Qingbo Xu, J. Kaski, J. Madrigal, 2004 .

A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.

W. Rosenberg, C. Muller, M. Whelan, 2018, Vaccine.

A year of successful cancer vaccines points to a path forward.

M. Morse, M. Whelan, 2010, Current opinion in molecular therapeutics.

Biomarkers for the Development of Cancer Vaccines

A. Dalgleish, J. Copier, M. Whelan, 2006, Molecular Diagnosis & Therapy.

Advances in prostate cancer immunotherapy.

H. Pandha, A. Dalgleish, E. Havranek, 2002, Surgical oncology.

HLA-B27 and effector T cells: arthritogenic peptide or arthritogenic antigen?

M. Whelan, J. Archer, 1993, The Lancet.

Effect of a free sulphydryl group on expression of HLA-B27 specificity.

M. Whelan, J. Archer, V. Winrow, 1990, Scandinavian journal of rheumatology. Supplement.

studied by flow cytometry . epitope : accessibility of the free cysteine Sulphydryl reactivity of the HLA-B 27

D. Perrett, M. Macey, M. Lowdell, 2022 .

HLA-B27 subtypes

M. Whelan, J. Archer, I. L. Maclean, 1991, The Lancet.

Phenotype That Drives Development of Th 2 Signals Dendritic Cells to Acquire a A Filarial Nematode-Secreted Product

M. Harnett, W. Harnett, M. Whelan, 2000 .

The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma model

A. Dalgleish, S. Todryk, S. Ward, 2006, Cancer Immunology, Immunotherapy.

Novel immunotherapeutic approaches to prostate cancer.

A. Dalgleish, M. Whelan, 2005, Current opinion in molecular therapeutics.

Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease

W. Barclay, M. Collins, M. Maini, 2013, Mucosal Immunology.

A Filarial Nematode-Secreted Product Signals Dendritic Cells to Acquire a Phenotype That Drives Development of Th2 Cells1

M. Harnett, W. Harnett, M. Whelan, 2000, The Journal of Immunology.

A method for the absolute quantification of cDNA using real-time PCR.

M. Whelan, J. Whelan, N. Russell, 2003, Journal of immunological methods.

Equine herpesvirus type 1 infects dendritic cells in vitro: stimulation of T lymphocyte proliferation and cytotoxicity by infected dendritic cells.

M. Whelan, A. Hamblin, N. Edington, 1999, Veterinary immunology and immunopathology.

Recombinant Technology A method for the absolute quantification of cDNA using real-time PCR

M. Whelan, J. Whelan, N. Russell, 2003 .

Tandem Fusion of Hepatitis B Core Antigen Allows Assembly of Virus-Like Particles in Bacteria and Plants with Enhanced Capacity to Accommodate Foreign Proteins

D. Stuart, D. Rowlands, R. Gilbert, 2015, PloS one.

Delayed Disease Progression after Allogeneic Cell Vaccination in Hormone-Resistant Prostate Cancer and Correlation with Immunologic Variables

Hardev Pandha, Graham Ball, Prabir Chakraborty, 2005, Clinical Cancer Research.

Assessments of hepatitis B virus-like particles and Crm197 as carrier proteins in melioidosis glycoconjugate vaccines

R. Field, S. Nepogodiev, N. Harmer, 2020, bioRxiv.

Cancer vaccines as a therapeutic modality: the long trek

M. Whelan, A. Dalgleish, 2006, Cancer Immunology, Immunotherapy.

Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses

Hardev Pandha, Mike Whelan, H. Pandha, 2004, Medical oncology.

Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate‐pulsed cells: a phase I/II study

James A. Hutchinson, H. Pandha, A. Dalgleish, 2004, BJU international.

Cancer immunotherapy: an embarrassment of riches?

A. Dalgleish, M. Whelan, N. Russell, 2003, Drug discovery today.

Allogeneic whole‐cell vaccine: a phase I/II study in men with hormone‐refractory prostate cancer

M. Perry, R. Kirby, S. Nicholson, 2002, BJU international.

Syndromes T Cells in Patients with Acute Coronary Null Cd28 + Heat-shock Protein 60-reactive Cd4 Heat-shock Protein 60 –reactive Cd4 Cd28 Null T Cells in Patients with Acute Coronary Syndromes

Qingbo Xu, J. Kaski, J. Madrigal, 2022 .